Amp Capital Investors LTD Novo Nordisk A S Transaction History

Amp Capital Investors LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $3.26 Million - $3.6 Million	-51,205 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.01 Million - $1.17 Million	-17,188 Reduced 25.13%	51,205 $3.36 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $1.66 Million - $2.18 Million	-33,597 Reduced 32.94%	68,393 $4.12 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $2.66 Million - $3.11 Million	53,386 Added 109.84%	101,990 $5.89 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $3.92 Million - $4.4 Million	-83,800 Reduced 63.29%	48,604 $2.47 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $2.9 Million - $3.3 Million	69,928 Added 111.93%	132,404 $6.07 Million
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $2.3 Million - $2.52 Million	49,211 Added 370.98%	62,476 $2.98 Million
Q2 2018 Aug 13, 2018	BUY	$44.29 - $50.42 $587,506 - $668,821	13,265 New	13,265 $612,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $875,341 - $1.05 Million	-18,052 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $858,011 - $969,933	18,052	18,052 $969,000

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.